Azithromycin-resistant syphilis-causing strains in Sydney, Australia: Prevalence and risk factors

Journal of Clinical Microbiology

Volumn 52, Issue 8, 2014, Pages 2776-2781

  Read, Phillip ^a,b,c   Jeoffreys, Neisha ^d   Tagg, Kaitlin ^d   Guy, Rebecca J ^c   Gilbert, Gwendolyn L ^d   Donovan, Basil ^a,c  

^a SYDNEY EYE HOSPITAL   (Australia)

^b Holdsworth House Medical Practice   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BACTERIAL DNA; MACROLIDE; ROXITHROMYCIN; ANTIINFECTIVE AGENT; RIBOSOME DNA;

ADULT; AGE; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; AUSTRALIA; BACTERIAL STRAIN; CHEMILUMINESCENCE IMMUNOASSAY; CLINICAL FEATURE; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG USE; ENZYME IMMUNOASSAY; FEMALE; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEN WHO HAVE SEX WITH MEN; NONHUMAN; OBSERVATIONAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; REAGIN TEST; RETROSPECTIVE STUDY; RISK FACTOR; SYPHILIS; TREPONEMA PALLIDUM; VERY ELDERLY; YOUNG ADULT; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; POINT MUTATION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; AUSTRALIA; AZITHROMYCIN; DNA, RIBOSOMAL; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SYPHILIS; TREPONEMA PALLIDUM; YOUNG ADULT;

EID: 84905245419     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00301-14     Document Type: Article

References (30)

1. World Health Organization. 2012. Global incidence and prevalence of selected curable sexually transmitted infections - 2008. World Health Organization, Geneva, Switzerland.
2. Read P, Donovan B. 2012. Clinical aspects of adult syphilis. Int. Med. J. 42:614-620. http://dx.doi.org/10.1111/j.1445-5994.2012.02814.x.
3. Wu Z, Xu J, Liu E, Mao Y, Xiao Y, Sun X, Liu Y, Jiang Y, McGoogan JM, Dou Z, Mi G, Wang N, Sun J, Liu Z, Wang L, Rou K, Pang L, Xing W, Xu J, Wang S, Cui Y, Li Z, Bulterys M, Lin W, Zhao J, Yip R, Wu Y, Hao Y, Wang Y, National MSM Survey Group. 2013. HIV and syphilis prevalence among men who have sex with men: a cross-sectional survey of 61 cities in China. Clin. Infect. Dis. 57:298-309. http://dx.doi.org/10.1093/cid/cit210.
4. Fenton K, Breben R, Vardavas R. 2008. Infectious syphilis in high-income settings in the 21st century. Lancet Infect. Dis. 8:244-253. http://dx.doi.org/10.1016/S1473-3099(08)70065-3. (Pubitemid 351391990)
5. Stamm WE, Handsfield HH, Rompalo AM, Ashley RL, Roberts PL, Corey L. 1988. The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA 260:1429-1433. http://dx.doi.org/10.1001/jama. 1988.03410100119036.
6. Guy RJ, Spelman T, Stoove M, El-Hayek C, Goller J, Fairley CK, Leslie D, Tee B, Roth N, Grulich AE, Hellard ME. 2011. Risk factors for HIV seroconversion in men who have sex with men in Victoria, Australia: results from a sentinel surveillance system. Sex Health 8:319-329. http://dx.doi.org/10.1071/SH10095.
7. Kirby Institute. 2013. HIV/AIDS, hepatitis C and sexually transmissible infections in Australia: annual surveillance report. University of New South Wales, Sydney, Australia.
8. Low N, Broutet N, Adu-Sarkodie Barton P, Hossain M, Hawkes S. 2006. Global control of sexually transmitted infections. Lancet 368:2001-2016. http://dx.doi.org/10.1016/S0140-6736(06)69482-8. (Pubitemid 44822624)
9. Riedner G, Rusizoka M, Todd J, Maboko L, Hoelscher M, Mmbando D, Samky E, Lyamuya E, Mabey D, Grosskurth H, Hayes R. 2005. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N. Engl. J. Med. 353:1236-1244. http://dx.doi.org/10.1056/NEJMoa044284. (Pubitemid 41345945)
10. Hook EW, III, Behets F, Van Damme K, Ravelomanana N, Leone P, Sena AC, Martin D, Langley C, McNeil L, Wolff M. 2010. A phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilis. J. Infect. Dis. 201:1729-1735. http://dx.doi.org/10.1086/652239.
11. Mitchell S, Engelman J, Kent C, Lukehart S, Godornes C, Klausner J. 2006. Azithromycin-resistant syphilis infection: San Francisco, California, 2000-2004. Clin. Infect. Dis. 42:337-345. http://dx.doi.org/10.1086/498899. (Pubitemid 43122308)
12. Grimes M, Sahi SK, Godornes BC, Tantalo LC, Roberts N, Bostick D, Marra CM, Lukehart SA. 2012. Two mutations associated with macrolide resistance in Treponema pallidum: increasing prevalence and correlation with molecular strain type in Seattle, Washington. Sex. Transm. Dis. 39:954-958. http://dx.doi.org/10. 1097/OLQ.0b013e31826ae7a8.
13. Lukehart SA, Godornes C, Molini BJ, Sonnett P, Hopkins S, Mulcahy F, Engelman J, Mitchell SJ, Rompalo AM, Marra CM, Klausner JD. 2004. Macrolide resistance in Treponema pallidum in the United States and Ireland. N. Engl. J. Med. 351:154-158. http://dx.doi.org/10.1056/NEJMoa040216.
14. Tipple C, McClure M, Taylor G. 2011. High prevalence of macrolide resistant Treponema pallidum strains in a London centre. Sex. Transm. Infect. 87:486-448. http://dx.doi.org/10.1136/sextrans-2011-050082.
15. Chen XS, Yin YP, Wei WH, Wang HC, Peng RR, Zheng HP, Zhang JP, Zhu BY, Liu QZ, Huang SJ. 2013. High prevalence of azithromycin resistance to Treponema pallidum in geographically different areas in China. Clin. Microbiol. Infect. 19:975-979. http://dx.doi.org/10.1111/1469-0691.12098.
16. Morshed M, Jones H. 2006. Treponema pallidum macrolide resistance in BC. CMAJ 174:349. http://dx.doi.org/10.1503/cmaj.1050256.
17. Van Damme K, Behets F, Ravelomanana N, Godornes C, Khan M, Randrianasolo B, Rabenja NL, Lukehart S, Cohen M, Hook E. 2009. Evaluation of azithromycin resistance in Treponema pallidum specimens from Madagascar. Sex. Transm. Dis. 36:775-776. http://dx.doi.org/10.1097/OLQ.0b013e3181bd11dd.
18. Muller E, Paz-Bailey G, Lewis D. 2012. Macrolide resistance testing and molecular subtyping of Treponema pallidum strains from southern Africa. Sex. Transm. Infect. 88:470-474. http://dx.doi.org/10.1136/sextrans-2011-050322.
19. Wu H, Chang SY, Lee NY, Huang WC, Wu BR, Yang CJ, Liang SH, Lee CH, Ko WC, Lin HH, Chen YH, Liu WC, Su YC, Hsieh CY, Wu PY, Hung CC. 2012. Evaluation of macrolide resistance and enhanced molecular typing of Treponema pallidum in patients with syphilis in Taiwan: a prospective multicenter study. J. Clin. Microbiol. 50:2299-2304. http://dx.doi.org/10.1128/JCM.00341-12.
20. Antibiotic Expert Group. 2010. Antibiotic version 14, 2010. Therapeutic Guidelines Ltd., Melbourne, Australia.
21. Shields M, Guy R, Jeoffreys N, Finlayson R, Donovan B. 2012. A longitudinal evaluation of Treponema pallidum PCR testing in early syphilis. BMC Infect. Dis. 12:353. http://dx.doi.org/10.1186/1471-2334-12-353.
22. Marra C, Colina A, Gordones C, Tantalo LC, Puray M, Centurion-Lara A, Lukehart SA. 2006. Antibiotic selection may contribute to increases in macrolide-resistant Treponema pallidum. J. Infect. Dis. 194:1771-1773. http://dx.doi.org/10.1086/509512.
23. Lee SY, Ning Y, Fenno JC. 2002. 23S rRNA point mutation associated with erythromycin resistance in Treponema denticola. FEMS Microbiol. Lett. 207:39-42. http://dx.doi.org/10.1111/j.1574-6968.2002.tb11025.x. (Pubitemid 34214803)
24. Martin I, Gu W, Yang Y, Tsang R. 2009. Macrolide resistance and molecular types of Treponema pallidum causing primary syphilis in Shanghai, China. Clin. Infect. Dis. 49:515-521. http://dx.doi.org/10.1086/600878.
25. Jin F, Prestage GP, Kippax SC, Pell CM, Donovan BJ, Kaldor JM, Grulich AE. 2005. Epidemic syphilis among homosexually active men in Sydney. Med. J. Aust. 183:179-183. https://www.mja.com.au/journal/2005/183/4/epidemic-syphilis- among-homosexually-active-men-sydney. (Pubitemid 41150322)
26. Azzato F, Ryan N, Fyfe J, Leslie D. 2012. Molecular subtyping of Treponema pallidum during a local syphilis epidemic in men who have sex with men in Melbourne, Australia. J. Clin. Microbiol. 50:1895-1899. http://dx.doi.org/ 10.1128/JCM.00083-12.
27. Katz KA, Pillay A, Ahrens K, Kohn RP, Hermanstyne K, Bernstein KT, Ballard RC, Klausner JD. 2010. Molecular epidemiology of syphilis: San Francisco, 2004-2007. Sex. Transm. Dis. 37:660-663. http://dx.doi.org/10.1097/ OLQ.0b013e3181e1a77a.
28. Matejková P, Flasarová M, Zákoucká H, Borek M, Kremenová S, Arenberger P, Woznicová V, Weinstock GM, Smajs D. 2009. Macrolide treatment failure in a case of secondary syphilis: a novel A2059G mutation in the 23S rRNA gene of Treponema pallidum subsp. pallidum. J. Med. Microbiol. 58:832-836. http://dx.doi.org/10.1099/jmm.0.007542-0.
29. Flasarova M, Pospisilova P, Mikalova L, Valisova Z, Dastychova E, Strnadel R, Kuklova I, Woznicova V, Zakoucka H, Smajs D. 2012. Sequencing-based molecular typing of Treponema pallidum strains in the Czech Republic: all identified genotypes are related to the sequence of the SS14 strain. Acta Derm. Venereol. 92:669-674. http://dx.doi.org/10.2340/00015555-1335.
30. Chen CY, Chi KH, Pillay A, Nachamkin E, Su JR, Ballard RC. 2013. Detection of the A2058G and A2059G 23S rRNA gene point mutations associated with azithromycin resistance in Treponema pallidum by use of a TaqMan real-time multiplex PCR assay. J. Clin. Microbiol. 51:908-913. http://dx.doi.org/10.1128/ JCM.02770-12.